Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Telomerase activation is a common feature of advanced human cancers and facilitates the malignant transformation of cultured human cells and in mice. These experimental observations are in accord with the presence of robust telomerase activity in more advanced stages of human colorectal carcinogenesis. However, the occurrence of colon carcinomas in telomerase RNA (Terc)-null, p53-mutant mice has revealed complex interactions between telomere dynamics, checkpoint responses and carcinogenesis. We therefore sought to determine whether telomere dysfunction exerts differential effects on cancer initiation versus progression of mouse and human intestinal neoplasia. In successive generations of ApcMin Terc-/- mice, progressive telomere dysfunction led to an increase in initiated lesions (microscopic adenomas), yet a significant decline in the multiplicity and size of macroscopic adenomas. That telomere dysfunction also contributes to human colorectal carcinogenesis is supported by the appearance of anaphase bridges (a correlate of telomere dysfunction) at the adenoma-early carcinoma transition, a transition recognized for marked chromosomal instability. Together, these data are consistent with a model in which telomere dysfunction promotes the chromosomal instability that drives early carcinogenesis, while telomerase activation restores genomic stability to a level permissive for tumor progression. We propose that early and transient telomere dysfunction is a major mechanism underly…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We monitored the anaphase bridge index (ABI), an in vivo biomarker of the degree of telomere dysfunction in dividing tissues that mirrors chromosomal fusion frequency, in successive mTerc -/ -generations (7, 30) (see Materials and Methods for definition of ABI).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“The GI crypts of lategeneration mTerc -/ -Ink4a / Arf + / + and -/ -mice exhibited equally high levels of apoptosis (Fig. 1 C ), comparable to that in late-generation mTerc -/ -tissues with intact p53 function (7, 30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“This finding differs from that of the mTerc Apc Min model, wherein telomere dysfunction promotes the initiation of intestinal carcinomas but inhibits their progression (30).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“findings consistent with previous studies establishing that telomere dysfunction acts as a tumor suppressor when p53 function is intact (7, 8, 30, 48).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [30]
In the citing paper
“Crosses of telomerase-deficient mice with various tumour model mice have demonstrated that critically short telomeres limit tumour formation when the p53 pathway is functional51–55.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [52]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“gif" NDATA ITEM> ]> Telomerase activation is a common feature of advanced human cancer”
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Epithelial cancers occur infrequently in laboratory mice, and when they do occur they rarely exhibit the aberrant cytogenetic profiles typical of human carcinomas, such as severe aneuploidy and complex nonreciprocal translocation”
BackgroundCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“and facilitates the malignant transformation of cultured human cell”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Together, the presence of short telomeres in colorectal carcinom”
BackgroundTHE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
McClintock, B. (1941) · Genetics · doi:10.1093/genetics/26.2.234 · Cited by 1,596
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591 · cited 1×
“In successive generations of Apc Min Terc −/− mic”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Self-citation
Cited by
Items 301–400 of 521
Acacetin and Chrysin, Two Polyphenolic Compounds, Alleviate Telomeric Position Effect in Human Cells
Boussouar, A., Barette, C., Nadon, R., Saint-Léger, A., Broucqsault, N., Ottaviani, A., Firozhoussen, A., Lu, Y., Lafanéchère, L., Gilson, É., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.42 · Cited by 22
Molecular Mechanisms of Colorectal Carcinogenesis
Roper, J., & Hung, K. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8412-7_2 · Cited by 30
“In mice defi cient in the RNA component of telomerase ( Terc −/−), telomere shortening results in aberrant crypt foci, adenomas, and gastrointestinal tumors (Rudolph et al. 2001 ; Plentz et al. 2003 ).”
BackgroundSelective pressures for and against genetic instability in cancer: a time-dependent problem
Komarova, N. L., Sadovsky, A. V., & Wan, F. Y. M. (2007) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.1054 · Cited by 23
“A paper by Rudolph et al. (2001) reports data on intestinal carcinoma in mice and humans which is consistent with a similar model: telomere dysfunction promotes chromosomal instability which drives carcinogenesis at early stages; and telomerase activation restores stability to allow further tumour…”
BackgroundSod2 haploinsufficiency does not accelerate aging of telomere dysfunctional mice
Guachalla, L. M., Ju, Z., Koziel, R., von Figura, G., Song, Z., Fusser, M., Epe, B., Jansen-Dűrr, P., & Rudolph, K. L. (2009) · Aging · doi:10.18632/aging.100030 · Cited by 21
“Whole mounts of colon were prepared as previously described [66].”
MethodSelf-citationPTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma
Zhou, X., Zhu, H., & Lu, J. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.11.016 · Cited by 22
Gastrointestinal cancer - only a deregulation of stem cell differentiation? (Review)
Neureiter, D., Herold, C., & Ocker, M. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.3.483 · Cited by 19
Cancer Stem Cells: From Bench to Bedside
Jones, R. J., & Matsui, W. H. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.10.010 · Cited by 21
Complex roles for telomeres and telomerase in breast carcinogenesis
Artandi, S. E. (2002) · Breast Cancer Research · doi:10.1186/bcr553 · Cited by 25
“Telomere uncapping in late-generation mTERC–/– p53+/+ mice resulted in impaired tumor formation when these mice were treated with chemical carcinogens [11], or studied on an INK4A–/– [12] or APC+/– [13] tumor-prone background.”
BackgroundTanaka, H., Beam, M. J., & Caruana, K. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.009 · Cited by 19
“It has been reported that there are 15% to 20% of anaphase bridges in tissue sections ranging from high-grade dysplasia to colon cancer, while there are less than 1% of anaphase bridges in adenoma [47].”
BackgroundWu, Y., Huang, C.-S., Hsieh, M., Huang, C.-M., Setiawan, S. A., Yeh, C., Kuo, K.-T., & Liu, S. (2024) · Aging · doi:10.18632/aging.205409 · Cited by 36
“This phenomenon has been demonstrated in previous studies [52].”
ResultStem cell function and maintenance – ends that matter: Role of telomeres and telomerase
Saeed, H., & Iqtedar, M. (2013) · Journal of Biosciences · doi:10.1007/s12038-013-9346-3 · Cited by 24
“…have shown that telomere shortening act through a complex modus operandi, i.e. enhancing the earliest events of tumor initiation, while concurrently inhibiting the progression and development of advanced macroscopic tumours (Greenberg et al. 1999; Gonzalez-Suarez et al. 2000; Rudolph et al. 2001).”
BackgroundHao, X., Yang, Y., Song, X., Zhao, X., Wang, L., He, J.-D., Kong, Q., Tang, N. L. S., & Zhang, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.2098 · Cited by 19
“This results in chromosome breakage and genomic copy number alterations (CNAs) and drives development of carcinomas (3,10).”
Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice
Kuno, T., Hatano, Y., Tomita, H., Hara, A., Hirose, Y., Hirata, A., Mori, H., Terasaki, M., Masuda, S., & Tanaka, T. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs348 · Cited by 21
“To examine the effects of organo-Mg in drinking water on chromosomal instability (24,25) in adenocarcinoma cells, the anaphase bridging index (ABI) was determined on hematoxylin and eosin–stained sections.”
BackgroundMethodDietary Tricin Suppresses Inflammation-Related Colon Carcinogenesis in Mice
Tanaka, T., Oyama, T., & SUGIE, S. (2019) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.65.s100 · Cited by 22
Njeru, S. N., Kraus, J. M., Meena, J. K., Lechel, A., Katz, S., Kumar, M., Knippschild, U., Azoitei, A., Wezel, F., Bolenz, C., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1073-2 · Cited by 26
Self-citationBenassi-Evans, B., Clifton, P. M., Noakes, M., & Fenech, M. F. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.08.009 · Cited by 19
Squamous cell carcinomas of the esophagus arise from a telomere-shortened epithelial field
Kammori, M., Poon, S. S. S., Nakamura, K., Izumiyama, N., Ishikawa, N., Kobayashi, M., Naomoto, Y., & Takubo, K. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.6.793 · Cited by 21
Radiation-induced chromosome breaks in ataxia-telangiectasia cells remain open
Martı́n, M., Genescà, A., Latre, L., Ribas, M., Miró, R., Egozcue, J., & Tusell, L. (2003) · International Journal of Radiation Biology · doi:10.1080/0955300031000089601 · Cited by 19
“In mammalian cells, non-homologous end-joining sequence of chromosome instability during tumour development (DePinho 2000, Rudolph et al. 2001).”
BackgroundIzumi, H., Hara, T., Oga, A., Matsuda, K., Sato, Y., Naito, K., & Sasaki, K. (2002) · Neoplasia · doi:10.1038/sj.neo.7900205 · Cited by 19
de Grey, A. D. N. J., Campbell, F. C., Dokal, I. S., Fairbairn, L., Graham, G. J., Jahoda, C. A. B., & PORTERG, A. C. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.026 · Cited by 19
“However, when these confounders are minimised, the effect is dramatic: in TERC Apc mice, a mild reduction in telomere length increased the incidence of cancer at a given age, but severe telomere shortening reduced that risk to the point where no deaths at all occurred by the age at which all TERC animals had died.(71)…”
BackgroundBenassi-Evans, B., Clifton, P. M., Noakes, M., Keogh, J. B., & Fenech, M. F. (2009) · Mutagenesis · doi:10.1093/mutage/gep006 · Cited by 19
“This view is supported by a study in models of rodent and human intestinal cancer in vivo, which observed a positive correlation with Npb formation and telomere shortening, further suggesting that Npbs may be used as a surrogate marker of critically short telomeres (33).”
Anticancer Therapy Targeting Telomeres and Telomerase: Current Status
Parkinson, E. K., & Minty, F. (2007) · BioDrugs · doi:10.2165/00063030-200721060-00005 · Cited by 22
Role of Telomere Dysfunction in Genetic Intratumor Diversity
Genescà, A., Pampalona, J., Frías-López, C., Domínguez, D., & Tusell, L. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-387688-1.00002-8 · Cited by 20
PinX1: a sought-after major tumor suppressor at human chromosome 8p23
Zhou, X. Z. (2011) · Oncotarget · doi:10.18632/oncotarget.339 · Cited by 18
“Maintaining optimal telomere length is crucial for cells since excessive telomere loss leads to telomere fusions, anaphase bridges, aberrant mitotic chromosome separation and aneuploidy [31-34].”
Telomerase as a novel and potentially selective target for cancer chemotherapy
Parkinson, E. K. (2003) · Annals of Medicine · doi:10.1080/07853890310006361 · Cited by 19
Telomerase as a clinical target: Current strategies and potential applications
Fleisig, H. B., & Wong, J. M. Y. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.011 · Cited by 22
Bisht, S., Mao, Y., & Easwaran, H. (2024) · Current Opinion in Oncology · doi:10.1097/cco.0000000000001020 · Cited by 19
Spontaneous Immortalization of Human Epidermal Cells with Naturally Elevated Telomerase
Rea, M. A., Zhou, L., Qin, Q., Barrandon, Y., Easley, K., Gungner, S. F., Phillips, M. A., Holland, W. S., Gumerlock, P. H., Rocke, D. M., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700424 · Cited by 18
“However, as the malignant cells that evolve need chromosome stability to grow well, telomerase deficiency can lead to a reduction in ultimate yield of advanced tumors (Rudolph et al., 2001).”
Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma
Kwong, L. N., Zou, L., Chagani, S., Pedamallu, C. S., Liu, M., Jiang, S., Protopopov, A. I., Zhang, J., Getz, G. A., & Chin, L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.065 · Cited by 19
“…tumor formation and progression in mice (Ding et al., 2012; Greenberg et al., 1999; Hu et al., 2012; Maser et al., 2007; Perera et al., 2008; Rudolph et al., 2001), and this suppression can be relieved through reactivation of telomerase (Ding et al., 2012; Hu et al., 2012) or, critically,…”
InfluentialWang, W., Wang, P., Wang, S., Duan, X., Wang, T., Feng, X., Li, L., Zhang, Y., Li, G.-Y., Zhao, J., et al. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.109453 · Cited by 17
To Fix or Not to Fix: Maintenance of Chromosome Ends Versus Repair of DNA Double-Strand Breaks
Casari, E., Gnugnoli, M., Rinaldi, C., Pizzul, P., Colombo, C. V., Bonetti, D., & Longhese, M. P. (2022) · Cells · doi:10.3390/cells11203224 · Cited by 22
“The role of telomere in malignancy and metastasis has been proved in telomerase-deficient checkpoint-mutated mice, in which telomere attrition promotes the development of epithelial cancers by a process of fusion-bridge breakage that leads to the formation of complex non-reciprocal translocations [144,204].”
BackgroundTelomeres and telomerase in normal and malignant B‐cells
Lobetti‐Bodoni, C., Bernocco, E., Genuardi, E., Boccadoro, M., & Ladetto, M. (2010) · Hematological Oncology · doi:10.1002/hon.937 · Cited by 18
“It is reasonable that the proliferative checkpoint function of telomeres represents a critical protection mechanism limiting the risk of tumour development in mammals, characterized by a prolonged life expectancy [5,35,49,54,55].”
BackgroundAltered States of Telomere Deprotection and the Two-Stage Mechanism of Replicative Aging
Zou, Y. S., Misri, S., Shay, J. W., Pandita, T. K., & Wright, W. E. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01569-08 · Cited by 20
“Anaphase bridges have frequently been used as a surrogate for end fusions and chromosome instability (27, 35).”
BackgroundŽelježić, D., Bjelis, M., & Mladinić, M. (2014) · Chemosphere · doi:10.1016/j.chemosphere.2014.05.085 · Cited by 20
“In a model of human intestinal cancer in vivo, an association was proven between the observed number of NPBs and critically short telomeres (Rudolph et al., 2001).”
BackgroundReing, J. E., Gollin, S. M., & Saunders, W. S. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2003.08.002 · Cited by 17
Duan, X., Yang, Y., Wang, S., Feng, X., Wang, T., Wang, P., Ding, M., Zhang, H., Liu, B., Wei, W., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.113995 · Cited by 16
Quantitative Fluorescence In Situ Hybridization (QFISH) of Telomere Lengths in Tissue and Cells
O'Sullivan, J. N., Finley, J. C., Risques, R.-A., Shen, W., Gollahon, K. A., & Rabinovitch, P. S. (2005) · Current Protocols in Cytometry · doi:10.1002/0471142956.cy1206s33 · Cited by 16
“Defects in telomere biology are one of the main mechanisms leading to the accumulation of chromosomal instability in early stages of cancer development (Rudolph et al., 2001; Meeker et al., 2002a; O’Sullivan et al., 2002; van Heek et al., 2002).”
BackgroundArgilla, D., Chin, K., Singh, M., Hodgson, J. G., Bosenberg, M., Ortíz-de-Solórzano, C., Lockett, S. J., DePinho, R. A., Gray, J. W., & Hanahan, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.032 · Cited by 19
Self-citationWalen, K. H. (2011) · Cell Biology International · doi:10.1042/cbi20110052 · Cited by 16
“Telomere dysfunction was associated with early prostate and colon cancerous developments (Rudolph et al., 2001; Meeker et al., 2002).”
BackgroundMouse models to study the role of telomeres in cancer, aging and DNA repair
Blasco, M. A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00450-1 · Cited by 18
Engineering cancer resistance in mice
Klatt, P., & Serrano, M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg057 · Cited by 16
Zane, L. K., Sibon, D., Capraro, V., Galia, P., Karam, M., Delfau‐Larue, M., Gilson, É., Gessain, A., Gout, O., Hermine, O., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26270 · Cited by 18
“Therefore, telomere dysfunctions can promote early carcinogenesis.(18) Telomerase is active in normal human peripheral blood T cells,(19) increases as lymphocytes enter the cell cycle after stimulation(20) and is downregulated during T-cell senescence.”
BackgroundThe abscission checkpoint senses chromatin bridges through Top2α recruitment to DNA knots
Petsalaki, E., Balafouti, S., Kyriazi, A. A., & Zachos, G. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202303123 · Cited by 15
Hua, Z., Lü, X., Li, S., Chen, D., & Liu, Q.-J. (2013) · Mutagenesis · doi:10.1093/mutage/get062 · Cited by 15
Dynamics of telomeric chromatin at the crossroads of aging and cancer
Ye, J., Wu, Y., & Gilson, É. (2010) · Essays in Biochemistry · doi:10.1042/bse0480147 · Cited by 17
“Interestingly, if telomere dysfunction in telomerase-deficient mice increases the incidence of cancer, the tumours usually remain in situ and are resistant to progression [44,45].”
BackgroundImmunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review
Samarth, N. H., Gulhane, P., & Singh, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1089320 · Cited by 18
“Chromosome instability brought on by telomere dysfunction may activate telomerase, activate oncogenes, and/or silence tumour suppressor genes, all of which work together to promote cancerous transformation, tumour growth, and drug resistance (21, 22).”
BackgroundLinks between telomere dysfunction and hallmarks of aging
Li, S., Liu, Z., Zhang, J., & Li, L. (2023) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2023.503617 · Cited by 16
Telomere dysfunction in chronic liver disease: The link from aging
Penrice, D. D., Jalan‐Sakrikar, N., Jurk, D., Passos, J. F., & Simonetto, D. A. (2023) · Hepatology · doi:10.1097/hep.0000000000000426 · Cited by 17
“[81] Thus, telomeres play a dual role in the development of malignancy; whereas telomere shortening promotes chromosomal instability and genetic anomalies that give rise to cancer, resulting cancer requires sufficient telomere and telomerase activity to proliferate.”
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome
Bozzao, C., Lastella, P., de Leòn, M. P., Pedroni, M., Gregorio, C. D., D'Ovidio, F. D., Resta, N., Prete, F., Guanti, G., & Stella, A. (2011) · Cancer · doi:10.1002/cncr.26022 · Cited by 14
“Conversely, shortened, dysfunctional telomeres cause genomic instability and, hence, predisposition to cancer development.(12) In the current study, we investigated whether variations in the length of telomeres in peripheral blood cells were correlated with earlier cancer onset in successive generations of patients wi…”
BackgroundTelomere uncapping at the crossroad between cell cycle arrest and carcinogenesis
Gobbini, E., Trovesi, C., Cassani, C., & Longhese, M. P. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29901 · Cited by 16
Telomere Length Study in Celiac Disease
Cottliar, A., Palumbo, M., Motta, G. L., de Barrio, S., Crivelli, A., Viola, M., Gómez, J. C., & Slavutsky, I. R. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08720.x · Cited by 14
“Experiments using murine models show that telomere dysfunction promotes telomere loss, aneuploidy, and chromosomal abnormalities, including end-to-end fusions (15, 16), supporting a role for telomere shortening in the induction of chromosome instability (17).”
BackgroundAnalysis of telomeric single‐strand overhang length in human endometrial cancers
Hashimoto, M., Kyo, S., Masutomi, K., Maida, Y., Sakaguchi, J., Mizumoto, Y., Nakamura, M., Hahn, W. C., & Inoue, M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.021 · Cited by 14
“instability, leading to cancer initiation [20].”
Escoffier, E., Rezza, A., de Climens, A. R., Belleville, A., Gazzolo, L., Gilson, É., & Dodon, M. D. (2005) · Retrovirology · doi:10.1186/1742-4690-2-77 · Cited by 19
“In human cells, a burst of telomere instability could also favor tumor formation [21,24-27].”
BackgroundTang, D., Qiu, R., Qiu, X., Sun, M., Su, M., Tao, Z., Zhang, L., & Tao, S. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2355693 · Cited by 15
Variation of the 3′ telomeric overhang lengths in human cells
Lee, M. E., Rha, S. Y., Jeung, H., Kim, T. S., Chung, H. C., & Oh, B.-K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.024 · Cited by 14
“Anaphase bridging was defined as an anaphase event in which more than two-thirds of the distance between anaphase poles was spanned by the bridging chromosome, to avoid the counting of lagging chromosomes [37].”
BackgroundTumor viruses and replicative immortality – Avoiding the telomere hurdle
Chen, X., Kamranvar, S. A., & Masucci, M. G. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.006 · Cited by 16
Telomerase Activity and the Risk of Lung Cancer
Jeon, H.-S., Choi, J. E., Jung, D. K., Choi, Y. Y., Kang, H. G., Lee, W.-K., Yoo, S. S., Lim, J.-O., & Park, J. Y. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.2.141 · Cited by 14
“However, in contrast to this hypothesis, studies of telomerase knockout mice found that telomere shortening induces chromosome instability, which is perpetuated through fusion-bridge-breakage cycles that increases the risk of cancer development (20-23).”
ResultPolymorphisms of TERT and CLPTM1L and the Risk of Hepatocellular Carcinoma in Chinese Males
Su, L., Li, X., Shen, L., Zhang, Y., Zhao, M., Yin, Z., Su, H., & Zhou, B. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.19.8197 · Cited by 13
Ghiaur, G., Gerber, J. M., Matsui, W. H., & Jones, R. J. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834ec015 · Cited by 14
“In fact, crossing telomerase knock-out mice with INK4a / [49] or APC [50] mice predisposed to cancer, significantly lowered the development of cancers in these mice.”
Chen, L., Zhu, X., Zou, Y., Xing, J., Gilson, É., Lu, Y., & Ye, J. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00321.2014 · Cited by 13
Wen, V. W., Wu, K., Baksh, S., Hinshelwood, R. A., Lock, R. B., Clark, S. J., Moore, M. A. S., & MacKenzie, K. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0979 · Cited by 14
Polychronopoulou, S., & Koutroumba, P. (2004) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200406000-00003 · Cited by 13
Telomere dysfunction alters intestinal stem cell dynamics to promote cancer
LaBella, K. A., Hsu, W.-H., Li, J., Qi, Y., Liu, Y., Liu, J., Wu, C.-C., Liu, Y., Song, Z., Lin, Y., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.03.020 · Cited by 15
Self-citationGong, P., Wang, H., Zhang, J., Fu, Y., Zhu, Z., Wang, J., Yin, Y., Wang, H., Zhou, Z., Yang, J., et al. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.05.010 · Cited by 13
Repair of DNA Broken Ends is Similar in Embryonic Fibroblasts with and without Telomerase
Latre, L., Genescà, A., Martín, M., Ribas, M., Egozcue, J., Blasco, M. A., & Tusell, L. (2004) · Radiation Research · doi:10.1667/rr3203 · Cited by 12
“Synthesis of telomeric repeats at these DSBs by telomerase would then help to control genetic instability by stabilizing the broken chromosome ends, preventing them from entering into further fusion-bridge-breakage cycles (10, 11).”
BackgroundThe role of telomere shortening in carcinogenesis: A hybrid stochastic-deterministic approach
Rodriguez-Brenes, I. A., Komarova, N. L., & Wodarz, D. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.09.003 · Cited by 15
Telomere dysfunction and telomerase activation in cancer – a pathological paradox?
Calcagnile, O., & Gisselsson, D. (2007) · Cytogenetic and Genome Research · doi:10.1159/000108310 · Cited by 14
“( c ) Mean frequencies of anaphase bridges (AB; red circles) and mean telomerase activity (TA) by TRAP assay (blue circles) during colorectal carcinogenesis; N = normal epithelium, LGA = low grade dysplastic adenoma, HGA = high-grade dysplastic adenoma, CIS = carcinoma in situ; ICA = invasive carcinoma; MET = metastas…”
BackgroundInfluentialIzumiyama‐Shimomura, N., Nakamura, K., Aida, J., Ishikawa, N., Kuroiwa, M., Hiraishi, N., Fujiwara, M., Ishikawa, Y., Inoshita, N., Yonese, J., et al. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.12.005 · Cited by 11
In colon cancer, normal colon tissue and blood cells have altered telomere lengths
Valls, C., Piñol, C., Reñé‐Espinet, J. M., Buenestado, J., & Salas, J. V. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23894 · Cited by 13
“Moreover, it is been associated with the initiation, and progression of human intestinal neoplasia [8,9].”
BackgroundWorldwide genetic structure in 37 genes important in telomere biology
Mirabello, L. J., Yeager, M., Chowdhury, S., Qi, L., Deng, X., Wang, Z., Hutchinson, A. A., & Savage, S. A. (2011) · Heredity · doi:10.1038/hdy.2011.55 · Cited by 12
“Short telomeres induce genetic instability and thereby promote the initiation and development of cancer (Blasco et al , 1997; Plentz et al , 2004; Plentz et al , 2003; Rudolph et al , 1999; Rudolph et al , 2001; Wu X, 2003).”
Li, Y., Xiang, C., Shen, N., Deng, L., Luo, X., Yuan, P., Ji, Z., Li, J., & Cheng, L. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.22980 · Cited by 12
Telomerase inhibitors: a new option for chemotherapy
Chen, Z., & Corey, D. R. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87173-7 · Cited by 14
Tumour morphology--interplay between chromosome aberrations and founder cell differentiation.
Gisselsson, D. (2002) · PubMed · doi:10.14670/hh-17.1207 · Cited by 15
Telomerase inhibitors: a new option for chemotherapy
Chen, Z. J., & Corey, D. R. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87294-9 · Cited by 11
Expression of the HPV18/E6 oncoprotein induces DNA damage
Cortés-Gutiérrez, E. I., García-Vielma, C., Aguilar‐Lemarroy, A., Vallejo‐Ruiz, V., Piña‐Sánchez, P., Zapata‐Benavides, P., & Gosálvez, J. (2017) · European Journal of Histochemistry · doi:10.4081/ejh.2017.2773 · Cited by 13
Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer
Styk, J., Buglyó, G., Pös, O., Csók, Á., Soltész, B., Lukasz, P., Repiská, V., Nagy, B., & Szemes, T. (2022) · Cancers · doi:10.3390/cancers14153712 · Cited by 10
“Progressive telomere shortening occurs in the intestinal epithelium during aging in humans, and telomere dysfunction (anaphase bridging) has been documented in the adenoma-carcinoma transition, indicating that a telomere-based crisis may play a role in driving CIN in the early stages of human CRC [49].”
BackgroundMechanisms of Gastrointestinal Malignancies
Katona, B. W., & Lynch, J. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00066-9 · Cited by 13
Telomerase: from Aging to Human Cancers
Parsa, N. (2012) · Springer eBooks · doi:10.1007/978-94-007-4632-9_1 · Cited by 17
Kucherlapati, R., & DePinho, R. A. (2001) · Nature · doi:10.1038/35079715 · Cited by 10
Self-citationThe Role of HeT-A and TART Retrotransposons in Drosophila Telomere Capping
Cenci, G., Siriaco, G., & Gatti, M. (2003) · Genetica · doi:10.1023/a:1022972902263 · Cited by 12
“Rudolph et al. (2001) showed that telomeric fusions occur at a particularly high frequency during adenoma–early carcinoma transition, but decline in the more advanced stages of tumor progression.”
BackgroundSahm, V., Maurer, H. C., Baumeister, T., Anand, A., Strangmann, J., Schmid, R. M., Wang, T. C., & Quante, M. (2022) · Oncotarget · doi:10.18632/oncotarget.28198 · Cited by 10
“While short telomeres alone in these late-generation mTERC-null mice can rescue the phenotype in cancer-prone mouse models [17– 19] and therefore act as a tumor suppressor, mild telomere dysfunction has been shown to be associated with tumor initiation [17, 20, 21].”
BackgroundPeng, L., & Waldman, S. A. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.3.12539 · Cited by 9
Prindull, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.009 · Cited by 9
“On the other hand, high telomerase activity in conjunction with genomic instability promotes neoplastic transformation [109,127–130].”
BackgroundTélomère et cancer : quoi de plus à la fin ?
Brunori, M., & Gilson, É. (2005) · médecine/sciences · doi:10.1051/medsci/200521137 · Cited by 15
“À l’inverse, chez la souris, l’inactivation de la télomérase rend les animaux plus résistants à la progression de certains cancers induits expérimentalement [6, 9-11].”
BackgroundAnalysis of Telomerase Activity and Telomere Function in Cancer
Gordon, K., & Parkinson, E. K. (2004) · Humana Press eBooks · doi:10.1385/1-59259-811-0:333 · Cited by 9
Finding of novel telomeric repeats and their distribution in the human genome
Alaguponniah, S., Krishna, D. V., Paul, S., Christyraj, J. R. S. S., Nallaperumal, K., & Sivasubramaniam, S. (2020) · Genomics · doi:10.1016/j.ygeno.2020.04.010 · Cited by 9
Mecanismos genéticos en la predisposición hereditaria al cáncer colorrectal
Alonso, Á., Moreno, S., Valiente, A., Artigas, M., Pérez-Juana, A., & Ramos‐Arroyo, M. A. (2006) · Anales del Sistema Sanitario de Navarra · doi:10.4321/s1137-66272006000100006 · Cited by 16
Escape from Cellular Senescence Is Associated with Chromosomal Instability in Oral Pre-Malignancy
Prime, S. S., Cirillo, N., & Parkinson, E. K. (2023) · Biology · doi:10.3390/biology12010103 · Cited by 11
“The result is the bulk population of cells escapes crisis and becomes immortal, thereby facilitating tumour progression [64,84,140,141].”
BackgroundModeling human endothelial cell transformation in vascular neoplasias
Wen, V. W., & MacKenzie, K. L. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012674 · Cited by 8
“Chromosomal instability accelerates the rate and accumulation of molecular changes that facilitate malignant transformation and tumor progression (Rudolph et al., 2001), including activation of a telomere maintenance mechanism, oncogene activation or silencing of tumor suppressor genes.”
BackgroundYu, S., Yin, Y., Wang, Q., & Wang, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.056 · Cited by 9
D ifferential senescence capacities in meibomian gland carcinoma and basal cell carcinoma
Zhang, L., Huang, X., Zhu, X., Ge, S., Gilson, É., Jia, R., Ye, J., & Fan, X. (2015) · International Journal of Cancer · doi:10.1002/ijc.29882 · Cited by 8
Telomerase as a Target for Cancer Therapeutics
Shay, J. W. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6102-0_13 · Cited by 10
Theophile, K., Buesche, G., Kreipe, H. H., & Bock, O. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0424-1 · Cited by 10
“The then less-protected chromosomal ends give rise to the frequently observed chromosomal aberrations [8].”
BackgroundCibler les télomères pour forcer les cellules cancéreuses à rentrer en sénescence
Londoño‐Vallejo, A., Lenain, C., & Gilson, É. (2008) · médecine/sciences · doi:10.1051/medsci/2008244383 · Cited by 13
“En accord avec un rôle oncosuppressif du dysfonctionnement télomérique chez l’homme, les souris de génération tardive, présentant des télomères courts, sont résistantes à certains processus de cancérisation [25-28].”
Telomerase and Cancer: A Complex Relationship
Fossel, M., & Whittemore, K. (2021) · OBM Geriatrics · doi:10.21926/obm.geriatr.2101156 · Cited by 7
The Ron receptor tyrosine kinase is not required for adenoma formation in ApcMin/+ mice
Meyer, S. E., Waltz, S. E., & Goss, K. H. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20551 · Cited by 7
“such as telomerase, to have different functions in normal tissue and at various stages of tumorigenesis [48].”
BackgroundTelomeres, cancer & aging: live long & prosper?
Eissenberg, J. C. (2013) · Europe PMC (PubMed Central) · Cited by 12
Fastest Time to Cancer by Loss of Tumor Suppressor Genes
Sanchez‐Tapia, C., & Wan, F. Y. M. (2014) · Bulletin of Mathematical Biology · doi:10.1007/s11538-014-0027-7 · Cited by 8
Zhang, Y., Zhou, J., Ye, Q., Zeng, K., Pan, J., Chen, L., Wang, Y., Yang, B., He, Q., Gao, J., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115079 · Cited by 7
Capping of Radiation-Induced DNA Breaks in Mouse Early Embryos
Tusell, L., Latre, L., Ponsa, I., Miró, R., Egozcue, J., & Genescà, A. (2004) · Journal of Radiation Research · doi:10.1269/jrr.45.415 · Cited by 7
Metadata
- Authors
- Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature Genetics
- Published
- 2001-06
- Volume
- 28
- Issue
- 2
- Pages
- 155-159
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1483245334
- Cited by
- 527
- References
- 31
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 18 · 2014: 16 · 2013: 26 · 2012: 27
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- telomere dysfunction, telomerase activation, colorectal carcinogenesis, chromosomal instability, ApcMin/+ mice, TP53 mutation, anaphase bridges, tumor progression, tumor initiation, genome stability
- MeSH terms
- Adenocarcinoma, Adenoma, Animals, Cytoskeletal Proteins, Humans, Intestinal Neoplasms, Mice, Inbred C57BL, Mice, Mutant Strains, RNA, Colorectal Neoplasms, Tumor Suppressor Protein p53, Telomere, Apoptosis, Telomerase, Adenomatous Polyposis Coli Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.